Siemens Healthineers Enhanced Liver Fibrosis Testing Service
Siemens Healthineers has launched its Enhanced Liver Fibrosis testing service in the US. The service is provided by the Siemens Healthcare Laboratory unit that can test samples submitted from all states in the US, Washington, DC, and Puerto Rico, excluding New York state. The test uses a small blood sample from a patient and provides a unitless numeric score that combines the quantitative measurements in a serum sample of three markers of liver fibrosis — hyaluronic acid, amino-terminal propeptide of type III procollagen, and tissue inhibitor of metalloproteinase. The score can help identify chronic liver disease patients, including those with non-alcoholic fatty liver disease, and stratify individuals at risk of progressing to liver-related events. Siemens noted that the test is not approved by the US Food and Drug Administration.